Pfizer and BioNTech Raise Price of COVID-19 Vaccine as UK Orders Booster Shots, Pfizer’s 2021 Sales Hit $11.3 Billion

Pfizer and BioNTech announced a price increase for COVID-19 booster shots—from £18 to £22. The European Union and the United Kingdom recently ordered additional doses as criticism surrounding pharma’s profiteering during the COVID-19 pandemic builds. In addition, the decision to provide booster shots while many countries face challenges in securing a stable vaccine supply is drawing attention and criticism. So far, Pfizer has hit $11.3 billion in sales for the year.

“The People’s Vaccine – a campaign involving more than 70 international organisations including Oxfam, UNAIDS and Save the Children – has said the cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies “weren’t profiteering from their monopolies” on COVID-19 vaccines.” Read more here.

(Source: Hugh Gosling, PMLive, 8/13/21)